 WALTHAM, Mass., April 07, 2022 GLOBE NEWSWIRE -- Xilio Therapeutics, Inc. Nasdaq: XLO, a biotechnology company developing tumor-selective immuno-oncology therapies for people living with cancer, today announced that Marty Huber, M.D., president of research and development and chief medical officer, will present at the 21st Annual Needham Virtual Healthcare Conference on Thursday, April 14, 2022, at 8:00 a.m. ET. 